仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Evolocumab （anti-PCSK9） is a human monoclonal antibody that inhibits PCSK9. Evolocumab binds to the circulating PCSK9 protein, inhibiting it from binding to the LDLR. Evolocumab can be used for the research of hypercholesterolemia and atherosclerotic cardiovascular diseases.